A chemist a UAlbany and his son are looking to make a major breakthrough in the world of Alzheimer's prevention. They believe ...

The new Alzheimer’s drug Kinsula is offering hope for patients by slowing down the progression of the disease. Neurologist Dr. Mauricio Concha administered the drug ...

AC Immune said its partner Life Molecular Imaging received fast-track designation from the U.S. Food and Drug Administration ... conditions: Alzheimer's disease, progressive supranuclear palsy ...

The FDA approved the drug based off a late-stage clinical ... “It’s very important to recognize those early symptoms of Alzheimer’s and to get diagnosed early so these treatments are an ...

Registered dietitian nutritionist Carrie Dennett explains what nicotinamide adenine dinucleotide, or NAD, is and if it has ...

The designation is granted for its use in Alzheimer’s disease ... degeneration. The FDA's Fast Track program expedites the development and review of drugs that treat serious conditions and ...

SO YOU CAN IMAGINE STUDIES ARE ALSO GOING TO BE DONE IN ALZHEIMER’S DISEASE. ADDICTION ... with type 2 diabetes.In order for the drug to get FDA approval for use in these people with heart ...

Digital twins are giving a shot in the arm to the costly, failure-prone drug-making process. But enormous data needs and ...

The designation is granted for its use in Alzheimer’s disease, progressive supranuclear palsy, and corticobasal degeneration. The FDA's Fast Track program expedites the development and review of drugs ...